Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... reported third-quarter results and 2009 guidance below analyst estimates. Amgen and Biogen both saw their share values drop 10 and 16 percent respectively. Biogen ...
2009 NOV 16 ... The third quarter of 2009 was a busy time in the renal anemia market. Findings from Amgen's TREAT study were released and AMAG Pharmaceuticals launched their new IV iron ...
2009 NOV 16 ... The third quarter of 2009 was a busy time in the renal anemia market. Findings from Amgen's TREAT study were released and AMAG Pharmaceuticals launched their new IV iron ...
2009 NOV 16 ... technique." Caliper invited pioneers in this field from Pfizer (PFE), Amgen (AMGN), and Biogen Idec (BIIB) to describe their analytical approaches for biologics ...
2009 NOV 23 ... From 1984 to 2002 he served with Immunex and, after Immunex' acquisition in 2002, with Amgen in positions ranging from Staff Scientist through Scientific Director. Dr. Cerretti ...
2009 NOV 16 ... of the Series A financing to $12 million. The company also engaged three new investors, Amgen Ventures, Broadview Ventures and The Peierls Foundation, who join founding investors ...
2009 NOV 23 ... Today's PriceWatch Alerts cover the following stocks: General Electric Co. (NYSE:GE), Amgen Inc. (NASDAQ:AMGN), Nike Inc. (NYSE:NKE), Green Mountain Coffee Roasters Inc. ...
2009 NOV 23 ... healthcare and luxury industries. The agency's healthcare clients include Amgen, Auxilium, Bayer, Becton Dickinson, Cephalon, Endo Pharmaceuticals, Life Line Screening, ...
2009 NOV 23 ... Genentech and Roche. Other ImmunoGen collaborative partners include Bayer HealthCare and Amgen. More information about ImmunoGen can be found at www.immunogen.com. ...
2009 NOV 16 ... to the efficacy demonstrated in separate trials for TNF-alpha inhibitors such as Amgen/Pfizer's Enbrel and Abbott's Humira, the two leading agents in the rheumatoid ...
2009 NOV 16 ... to Celgene's Apremilast, another TNF blocker, the pipeline includes two candidates from Amgen that take a new approach to inflammation by inhibiting Interkeulin-1 and Interleukin-15. ...
2009 NOV 16 ... by a fluorescence-based chromatography method," wrote Z.Q. Zhang and colleagues, Amgen, Inc. The researchers concluded: "This large-scale method may potentially ...
2009 NOV 23 ... as a noncytokine (GFP) shows similar behavior," wrote U. Martin and colleagues, Amgen, Inc. The researchers concluded: "That IL-1F6 can be externalized via a ...
2009 NOV 23 ... and substantially alter patient flow to currently marketed biologic agents, including Amgen's Enbrel and Abbott's Humira. Humira will suffer the most as the agent garners use as ...
2009 NOV 16 ... the university in 2005, Mr. Ashton held a number of senior executive positions at Amgen Inc., including Business Unit Vice President/General Manager of Corporate Accounts and ...
